Andrew J. Carroll

31.9k total citations · 4 hit papers
251 papers, 12.5k citations indexed

About

Andrew J. Carroll is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Andrew J. Carroll has authored 251 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Hematology, 154 papers in Public Health, Environmental and Occupational Health and 70 papers in Molecular Biology. Recurrent topics in Andrew J. Carroll's work include Acute Lymphoblastic Leukemia research (152 papers), Acute Myeloid Leukemia Research (123 papers) and Chronic Myeloid Leukemia Treatments (73 papers). Andrew J. Carroll is often cited by papers focused on Acute Lymphoblastic Leukemia research (152 papers), Acute Myeloid Leukemia Research (123 papers) and Chronic Myeloid Leukemia Treatments (73 papers). Andrew J. Carroll collaborates with scholars based in United States, Canada and Germany. Andrew J. Carroll's co-authors include Clara D. Bloomfield, Krzysztof Mrózek, Richard A. Larson, Jonathan E. Kolitz, Michael J. Borowitz, Meenakshi Devidas, Stephen P. Hunger, Guido Marcucci, William L. Carroll and Bruce M. Camitta and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Andrew J. Carroll

240 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

2010 548 citations Guido Marcucci, Kati Maharry et al. Journal of Clinical Oncology profile →
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

2008 542 citations Michael J. Borowitz, Meenakshi Devidas et al. Blood profile →
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

1998 508 citations Clara D. Bloomfield, John C. Byrd et al. profile →
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

2014 304 citations Kirk R. Schultz, Andrew J. Carroll et al. Leukemia profile →

Peers

Countries citing papers authored by Andrew J. Carroll

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Carroll more than expected).

Fields of papers citing papers by Andrew J. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Carroll. The network helps show where Andrew J. Carroll may publish in the future.

Co-authorship network of co-authors of Andrew J. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Carroll. A scholar is included among the top collaborators of Andrew J. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Carroll. Andrew J. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adolescent Depression and Cognition Risk for Suicide: An Investigation of Risk Factors and Gene Environment Interactions 2025 ·Brain and Behavior ·(unknown), (unknown), (unknown), Steven M. Holland, (unknown), Andrew J. Carroll, (unknown), (unknown), (unknown)	1
2	Association of social deprivation with survival in younger adult patients with AML: an Alliance study 2023 ·Blood Advances ·(unknown), Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly, Shelley Orwick, Karilyn Larkin, Christopher C. Oakes, Andrew Hantel, Andrew J. Carroll, William Blum, Bayard L. Powell, Geoffrey L. Uy, Richard M. Stone, Richard A. Larson, John C. Byrd, Electra D. Paskett, Jesse J. Plascak, Ann‐Kathrin Eisfeld	5
3	Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse 2023 ·Journal of Clinical Oncology ·Laura Hogan, Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Teena Bhatla, Michael J. Borowitz, Elizabeth A. Raetz, Andrew J. Carroll, Nyla A. Heerema, Gerhard Zugmaier, Elad Sharon, M. Brooke Bernhardt, Stephanie Terezakis, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh	33
4	Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study 2023 ·Leukemia ·Krzysztof Mrózek, Jessica Kohlschmidt, James S. Blachly, Deedra Nicolet, Andrew J. Carroll, Kellie J. Archer, Alice S. Mims, Karilyn Larkin, Shelley Orwick, Christopher C. Oakes, Jonathan E. Kolitz, Bayard L. Powell, William Blum, Guido Marcucci, Maria R. Baer, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Ann‐Kathrin Eisfeld	31
5	Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232 2021 ·Leukemia ·Michael J. Burke, Meenakshi Devidas, Zhiguo Chen, Wanda L. Salzer, Elizabeth A. Raetz, Karen R. Rabin, Nyla A. Heerema, Andrew J. Carroll, Julie M. Gastier‐Foster, Michael J. Borowitz, Brent L. Wood, Naomi Winick, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Eric Larsen	12
6	Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331 2021 ·Journal of Clinical Oncology ·Leonard A. Mattano, Meenakshi Devidas, Kelly W. Maloney, Cindy Wang, Alison M. Friedmann, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier‐Foster, Nyla A. Heerema, Nina S. Kadan‐Lottick, Yousif Matloub, David T. Marshall, Linda C. Stork, Mignon L. Loh, Elizabeth A. Raetz, Brent L. Wood, Stephen P. Hunger, William L. Carroll, Naomi Winick	22
7	HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions 2021 ·Leukemia ·Elspeth A. Bruford, Cristina R. Antonescu, Andrew J. Carroll, Arul M. Chinnaiyan, Ian A. Cree, Nicholas C.P. Cross, Raymond Dalgleish, Robert Peter Gale, Christine J. Harrison, (unknown), Jean‐Loup Huret, Bertil Johansson, Michelle Le Beau, Cristina Mecucci, Fredrik Mertens, Roel G.W. Verhaak, Felix Mitelman	47
8	Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932 2019 ·Blood ·Anne Angiolillo, Reuven J. Schore, John A. Kairalla, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler‐McKay, Michael J. Borowitz, Brent L. Wood, Andrew J. Carroll, Nyla A. Heerema, Mary V. Relling, (unknown), Kelly W. Maloney, Cindy Wang, William L. Carroll, Naomi Winick, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger	4
9	Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia 2019 ·Molecular Cancer Therapeutics ·Dimitrios Papaioannou, Deedra Nicolet, Hatice Gülçin Özer, Krzysztof Mrózek, Stefano Volinia, Paolo Fadda, Andrew J. Carroll, Jessica Kohlschmidt, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield	12
10	Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high‐risk stratum of patients with newly diagnosed high‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131 2017 ·Cancer ·Wanda L. Salzer, Michael J. Burke, Meenakshi Devidas, Si Chen, Lia Gore, Eric Larsen, Michael J. Borowitz, Brent L. Wood, Nyla A. Heerema, Andrew J. Carroll, Joanne M. Hilden, Mignon L. Loh, Elizabeth A. Raetz, Naomi Winick, William L. Carroll, Stephen P. Hunger	39
11	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category 2017 ·Blood ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Alice S. Mims, Christopher J. Walker, James S. Blachly, Deedra Nicolet, Shelley Orwick, (unknown), Andrew J. Carroll, Bayard L. Powell, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield	0
12	Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies 2017 ·Blood ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, James S. Blachly, Christopher J. Walker, Deedra Nicolet, Shelley Orwick, Andrew J. Carroll, Richard M. Stone, Eunice S. Wang, Jonathan E. Kolitz, Bayard L. Powell, Albert de la Chapelle, John C. Byrd, Clara D. Bloomfield	0
13	Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality 2016 ·Cancer Research ·Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, Stefano Volinia, James S. Blachly, Deedra Nicolet, Christopher C. Oakes, (unknown), Shelley Orwick, Andrew J. Carroll, Richard M. Stone, John C. Byrd, Albert de la Chapelle, Clara D. Bloomfield	16
14	Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331 2014 ·Blood ·Leonard A. Mattano, Meenakshi Devidas, Alison M. Friedmann, Elizabeth A. Raetz, Mignon L. Loh, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier‐Foster, Nyla A. Heerema, Nina S. Kadan‐Lottick, Yousif Matloub, David T. Marshall, Linda C. Stork, Brent L. Wood, Naomi Winick, Stephen P. Hunger, William L. Carroll, Kelly W. Maloney	13
15	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia 2010 ·Blood ·Richard C. Harvey, Charles G. Mullighan, I‐Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman	395
16	Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study 2009 ·Journal of Clinical Oncology ·Heiko Becker, Guido Marcucci, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Dean Margeson, Susan P. Whitman, Yue-Zhong Wu, Sebastian Schwind, Peter Paschka, Bayard L. Powell, Thomas H. Carter, Jonathan E. Kolitz, Meir Wetzler, Andrew J. Carroll, Maria R. Baer, Michael A. Caligiuri, Richard A. Larson, Clara D. Bloomfield	241
17	Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study 2009 ·Journal of Clinical Oncology ·Kirk R. Schultz, W. Paul Bowman, Alexander Aledo, William B. Slayton, Harland N. Sather, Meenakshi Devidas, Chenguang Wang, Stella M. Davies, Paul S. Gaynon, Michael E. Trigg, Robert Rutledge, Laura Burden, (unknown), Andrew J. Carroll, Nyla A. Heerema, Naomi Winick, Michael J. Borowitz, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta	436
18	Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study 2008 ·Journal of Clinical Oncology ·Guido Marcucci, Kati Maharry, Michael D. Radmacher, Krzysztof Mrózek, Tamara Vukosavljevic, Peter Paschka, Susan P. Whitman, Christian Langer, Claudia D. Baldus, Chang‐Gong Liu, Amy S. Ruppert, Bayard L. Powell, Andrew J. Carroll, Michael A. Caligiuri, Jonathan E. Kolitz, Richard A. Larson, Clara D. Bloomfield	224
19	Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201 2007 ·Blood ·Allen R. Chauvenet, Paul L. Martin, Meenakshi Devidas, Stephen B. Linda, Beverly Bell, Joanne Kurtzberg, Jeanette Pullen, Mark J. Pettenati, Andrew J. Carroll, Jonathan J. Shuster, Bruce M. Camitta	40
20	Therapeutic Trial for Infant Acute Lymphoblastic Leukemia: The Pediatric Oncology Group Experience (POG 8493) 1997 ·The American journal of pediatric hematology/oncology ·(unknown), J Ochs, Jonathan J. Shuster, Ronald L. Dubowy, W. Paul Bowman, Marilyn Hockenberry‐Eaton, Michael J. Borowitz, Andrew J. Carroll, C. Philip Steuber, DJ Pullen	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact